Abstract:This review synthesized the literature for barriers to HCV antiviral treatment in persons with HIV/HCV co-infection. Searches of PubMed, Embase, CINAHL, and Web of Science were conducted to identify relevant articles. Articles were excluded based on the following criteria: study conducted outside of the United States, not original research, pediatric study population, experimental study design, non-HIV or non-HCV study population, and article published in a language other than English. Sixteen studies met criteria and varied widely in terms of study setting and design. Hepatic decompensation was the most commonly documented absolute/nonmodifiable medical barrier. Substance use was widely reported as a relative/modifiable medical barrier. Patient-level barriers included nonadherence to medical care, refusal of therapy, and social circumstances. Provider-level barriers included provider inexperience with antiviral treatment and/or reluctance of providers to refer patients for treatment. There are many ongoing challenges that are unique to managing this patient population effectively. Documenting and evaluating these obstacles are critical steps to managing and caring for these individuals in the future. In order to improve uptake of HCV therapy in persons with HIV/HCV co-infection, it is essential that barriers, both new and ongoing, are addressed, otherwise, treatment is of little benefit.

Highly Enantioselective [3 + 2] Annulation of 3-Butynoates with Β-Trifluoromethyl Enones Promoted by an Amine−Phosphine Binary Catalytic System

Enantioselective One‐Pot Reaction: Organocatalyzed Synthesis of Fully Functionalized Oxabicyclo[2.2.2]octanes with Seven Contiguous Stereocenters

Highly Enantioselective [4 + 2] Annulations Catalyzed by Amino Acid-Based Phosphines: Synthesis of Functionalized Cyclohexenes and 3-Spirocyclohexene-2-oxindoles

Highly Enantioselective [3+2] Cycloadditions of Terminal Allenoates with Β-Trifluoromethyl Α,β-Enones.

Enantioselective Synthesis of Cyclopentanes by Phosphine-Catalyzed β,γ-Annulation of Allenoates

Phosphine-Catalyzed Sequential [3 + 2]/[3 + 2] Annulation between Allenoates and Arylidenemalononitriles for the Enantioselective Construction of Bicyclo[3,3,0]octenes and Cyclopenta[c]quinolinones

Enantioselective formal (3 + 3) cycloaddition of bicyclobutanes with nitrones enabled by asymmetric Lewis acid catalysis

N-Heterocyclic carbene-catalyzed enantioselective hetero-[10 + 2] annulation

Barriers to hepatitis C antiviral therapy in HIV/HCV co-infected patients in the United States: a review.

Enantioselective Dearomative [3 + 2] Umpolung Annulation of N -Heteroarenes with Alkynes

Rhodium-Catalyzed Asymmetric Annulation of Unactivated Alkynes with 3-(ortho-Boronated Aryl) Conjugated Enones: Enantioselective Synthesis of 2,3-Disubstituted Indenes.

Asymmetric [3 + 3] Annulation to Construct Trifluoromethylated Pyrazolo[3,4-b]pyridin-6-ones Via Chiral Phosphoric Acid and MgSO4 Synergistic Catalysis.

Phosphine-catalyzed Enantioselective [3 + 2] Cycloadditions of Γ-Substituted Allenoates with Β-Perfluoroalkyl Enones

Enantioselective Desymmetrization of Cyclobutanones Enabled by Synergistic Palladium/Enamine Catalysis

Enantioselective Phosphine-Catalyzed [6+1] Annulations of α-Allyl Allenoates with 1,1-Bisnucleophiles

ChemInform Abstract: Highly Enantioselective [4 + 2] Annulations Catalyzed by Amino Acid‐Based Phosphines: Synthesis of Functionalized Cyclohexenes and 3‐Spirocyclohexene‐2‐oxindoles.

Enantioselective Synthesis of Isoxazolines Enabled by Palladium‐Catalyzed Carboetherification of Alkenyl Oximes

Phosphine-Catalyzed Asymmetric Tandem Isomerization/Annulation of Allyl Amines with Allenoates: Enantioselective Annulation of a Saturated C–N Bond

Rhodium/Ming-Phos-catalyzed Asymmetric Annulation Reaction of Silacyclobutanes with Terminal Alkynes

Chiral CpxRhodium(III)‐Catalyzed Enantioselective Aziridination of Unactivated Terminal Alkenes

L-Phenylalanine potassium catalyzed asymmetric formal [3 + 3] annulation of 2-enoyl-pyridine N-oxides with acetone